Tempol Lowers Blood Pressure and Sympathetic Nerve Activity But Not Vascular O2− in DOCA-Salt Rats

Hypertension

Volumn 43, Issue 2, 2004, Pages 329-334

  Xu, Hui ^a   Fink, Gregory D ^a   Galligan, James J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Antioxidants; Blood pressure; Super oxide

Indexed keywords

APOCYNIN; DEOXYCORTICOSTERONE ACETATE; HYDROETHIDINE; SUPEROXIDE; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE MACROGOL; TEMPOL; URETHAN;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; BOLUS INJECTION; CAVA VEIN; CONFERENCE PAPER; CONFOCAL LASER MICROSCOPY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSOR RESPONSE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FLUORESCENCE MICROSCOPY; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SYMPATHETIC NERVE; SYMPATHETIC TONE; TISSUE LEVEL; TISSUE SECTION;

ACETOPHENONES; ANIMALS; ANTIOXIDANTS; AORTA; BLOOD PRESSURE; CYCLIC N-OXIDES; DESOXYCORTICOSTERONE; HEART RATE; HYPERTENSION; KIDNEY; POLYETHYLENE GLYCOLS; RATS; SODIUM CHLORIDE; SPIN LABELS; SUPEROXIDE DISMUTASE; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM; VENAE CAVAE;

EID: 0842268293     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000112304.26158.5c     Document Type: Article

References (37)

1. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases-The role of oxidase stress. Cir Res. 2000; 87: 840-844.
2. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase-Role in cardiovascular biology and disease. Cir Res. 2000; 86: 494-501.
3. Lassègue B, Clempus RE. Vascular NA(P)H oxidases: specific features, expression, and regulation. Am J Phyiol Regul Comp Physiol. 2003; 285: R277-R297.
4. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens. 1998; 16: 1267-1271.
5. Duffy SJ, Gokce N, Holbrook M, Hunter LM, Biogelsen ES, Huang A, Keaney JF, Vita JF. Effect of ascorbic acid treatment on conduit vessel endothelia dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol. 2001; 280: H528-H534.
6. Xu H, Fink GD, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol. 2002; 283: H885-H892.
7. Grossmann M, Dobrev D, Himmel HM, Ravens U, Kirch W. Ascorbic acid-induced modulation of venous tone in humans. Hypertension. 2001; 37: 949-954.
8. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998; 32: 59-64.
9. Xu H, Fink GD, Chen A, Watts S, Galligan JJ. Nitric oxide-independent effects of tempol on renal sympathetic nerve activity and blood pressure in normotensive rats. Am J Physiol Heart Circ Physiol. 2001; 281: H975-H980.
10. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension. 2003; 41: 266-273.
11. Fink GD, Watts S, Chen A, Xu H, Galligan JJ. Superoxide anion contributes to hypertension during chronic inhibition of nitric oxide synthesis. Hypertension. 2002; 40: 380.
12. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin f2α. Hypertension. 1999; 33: 424-428.
13. Ortiz MC, Manriquez MC, Romero JC, Juncos LA. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension. 2001; 38: 655-659.
14. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 2001; 37: 781-786.
15. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension. 2003; 41: 1346-1352.
16. Hoagland KM, Maier KG, Roman RJ. Contributions of 20-HETE to the antihypertensive effects of tempol in Dahl salt-sensitive rats. Hypertension. 2003; 41: 697-702.
17. Zhang Y, Jang R, Mori TA, Croft KD, Schyvens CG, Mckenzie KU. The antioxidant tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. J Hypertens. 2003; 21: 1513-1518.
18. Rajagopalan S, Kuiz S, Műnzel T, Tarpey M, Freeman BA, Griendling KK. Angiotensin I-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation-Contribution to alteration of vasomotor tone. J Clin Invest. 1996; 95: 588-593.
19. Ulker S, Mckeown PP, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension. 2003; 41: 534-539.
20. Beswick RA, Dorrance AM, Leite R, Webb RC. NADP/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertension. Hypertension 2001; 38: 1107-1111.
21. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 2001; 37: 529-534.
22. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension. 2002; 40: 755-762.
23. Schleien CL, Eberle B, Shaffner DH, Koehler RC, Traystman RJ. Reduced blood- brain barrier permeability after cardiac arrest by conjugated superoxide dismutase and catalase in piglets. Stroke. 1994; 25: 1830-1835.
24. Nguyen WD, Kim DH, Alam HB, Provido HS, Kirkpatrick JR. Polyethylene glycol- superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury. Crit Care. 1999; 3: 127-130.
25. Fink GD, Johnson RJ, Galligan JJ. Mechanisms of increased venous smooth muscle tone in deoxycorticosterone acetate-salt hypertension. Hypertension. 2000; 35: 464-469.
26. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension-the role of superoxide anion. Hypertension. 1999; 34: 539-545.
27. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation. 2000; 101: 1722-1728.
28. Thannickal V, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L1005-1028.
29. Guzik TJ, West NEJ, Pillai R, Taggart DP, Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 2002; 39: 1088-1094.
30. DeChamplin J. Pre- and postsynaptic adrenergic dysfunction in hypertension. J Hypertens. 1990; 8: S77-S85.
31. Shokoji T, Nishiyama A, Fujisawa Y, Kiyomoto H, Takahashi N, Hitomi H, Kimura S, Kono M, Abe Y. Effects of local administration of tempol and DETC on renal sympathetic never activity. XVth Scientific Meeting of the Inter-Am Society of Hypertension, San Antonio, TX; April 27-30, 2003; P33.
32. Gutierrez JA, Clark SG, Giulumian AD, Fuchs LC. Superoxide anions contribute to impaired regulation of blood pressure by nitric oxide during the development of cardiomyopathy. J Pharmacol Exp Ther. 1997; 282: 1643-1649.
33. Wu R, Millette E, Wu L, Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and deoxycorticosterone acetate- salt hypertensive rats. J Hypertens. 2001; 19: 741-718.
34. Kuppusamy P, Wang P, Shankar RA, Ma L, Trimble CE, Hsia CJ, Zweier JL. In vivo topical EPR spectroscopy and imaging of notroxide free radical and polynitrooxyl- albumin. Magn Reson Med. 1998; 40: 806-811.
35. Schoonmaker GC, Fallet RW, Carmines PK. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus. Am J Physiol Renal Physiol. 2000; 278: F302-F309.
36. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, Granger JP. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension. 2003; 42: 806-810.
37. Nishiyama A, Fukui T Fujisawa Y, Rahman M, Tian RX, Kimura S, Abe Y. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension. 2001; 37: 77-83.